Background Drugs prescribed for psychiatric disorders in adolescence should be studied
very extensively since they can affect developing and thus highly plastic brain differently …

The hippocampus is one of the few privileged regions (neural stem cell niche) of the brain,
where neural stem cells differentiate into new neurons throughout adulthood. However …

Sugar has become embedded in modern food and beverages. This has led to
overconsumption of sugar in children, adolescents, and adults, with more than 60 countries …

Aims Fluoxetine (FLX) is a common selective serotonin reuptake inhibitor, which is used in
adolescents with psychiatric disorders. Controversial results have been obtained in different …

Ketamine has shown promising antidepressant efficacy for adolescent treatment-resistant
depression. However, the potential enduring consequences of ketamine exposure have not …

Background Stress-induced illnesses, like major depression, are among the leading causes
of disability across the world. Consequently, there is a dire need for the validation of …

Background Ketamine (KET) is administered to manage major depression in adolescent
patients. However, the long-term effects of juvenile KET exposure on memory-related tasks …

The objective of this study was to evaluate whether juvenile fluoxetine (FLX) exposure
induces long-term changes in baseline responses to anxiety-inducing environments, and if …

Mood-related disorders have a high prevalence among children and adolescents, posing a
public health challenge, given their adverse impact on these young populations. Treatment …

Ketamine, a noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist, produces
quick and effective antidepressant results in depressed juvenile and adult individuals. The …